A distributor reported that a patient alleged skin irritation, described as a blister/burn in two areas of the chest, that began approximately one week after monitoring using 3m¿ red dot¿ ecg repositionable soft cloth monitoring electrodes, 2660-5.The patient informed the distributor of the alleged symptoms after approximately 20 days of monitoring and had disconnected the monitoring system.Upon follow-up by the distributor one month later, the patient reported that the skin was pink and peeling.The patient visited her cardiologist and no treatment was prescribed.A medwatch report was received by the distributor (mw5078271) that the patient had submitted to the fda which indicated that an area in the center of the chest looked to be a permanent scar.
|